Anti-inflammatory
DG01985 Disease modifying anti-rheumatic drug (DMARD)
Remark
Therapeutic category:
4420
ATC code:
M01CC02
Product:
D01809<JP>
Efficacy
Antirheumatic
Interaction
Structure map
map07050
Antirheumatics - DMARDs and biological agents
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M01C SPECIFIC ANTIRHEUMATIC AGENTS
M01CC Penicillamine and similar agents
M01CC02 Bucillamine
D01809 Bucillamine (JP18/INN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
44 Allergic agents
442 Stimulation therapy agents
4420 Stimulation therapy agents
D01809 Bucillamine (JP18/INN)
Drug groups [BR:br08330]
Anti-inflammatory
DG01985 Disease modifying anti-rheumatic drug (DMARD)
D01809 Bucillamine
Drug classes [BR:br08332]
Antirheumatic agent
DG01985 Disease modifying anti-rheumatic drug (DMARD)
D01809 Bucillamine
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D01809 Bucillamine
D01809 Bucillamine tablets
Other DBs
CAS:
65002-17-7
PubChem:
7848871
ChEBI:
31312
LigandBox:
D01809
NIKKAJI:
J22.800A
KCF data
ATOM 13
1 C6a C 19.8800 -16.3800
2 C1c C 21.0700 -17.0800
3 O6a O 18.6200 -17.0800
4 O6a O 19.8800 -14.9800
5 C1b C 22.2600 -16.3800
6 S1a S 23.4500 -17.0800
7 N1b N 21.0700 -18.4800
8 C5a C 19.8576 -19.1800
9 C1d C 19.8575 -20.5798
10 O5a O 18.6621 -18.4896
11 C1a C 18.6619 -21.2702
12 S1a S 21.0868 -21.2897
13 C1a C 18.6621 -19.8895
BOND 12
1 1 2 1
2 1 3 1
3 1 4 2
4 2 5 1
5 5 6 1
6 2 7 1 #Down
7 7 8 1
8 8 9 1
9 8 10 2
10 9 11 1
11 9 12 1
12 9 13 1